Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Feb 16;2(1):12–19. doi: 10.1159/000200015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2009 by S. Karger AG, Basel

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.

PMC Copyright notice

Fig. 1 — Carcinoembryonic antigen (CEA) serum levels over time. CEA levels (ng/ml) were measured using standardized laboratory tests (Roche, Germany) from routine blood samples to measure disease activity and therapy effects. The indicated chemotherapies were given as depicted (arrows). Gem = Gemcitabine 1,000 mg/m² (d1, 8); Cis = cisplatin 70 mg/m² (d1) q 21d; Carbo = carboplatin AUC 5 (d1); erlotinib 150 mg/d, pemetrexed 500 mg mg/m² q 21d; docetaxel 75 mg/m² q21d; vinorelbin 25 mg/m² weekly. Pericardial fenestration to the left pleural space was performed because of symptomatic therapy-resistant pericardial effusion.